{
  "retracted": false,
  "timestamp": 1426723200000,
  "updates": [
    {
      "timestamp": 1586551714961,
      "identifier": {
        "doi": "10.1007/s12032-015-0482-5"
      },
      "type": "correction"
    }
  ],
  "identifier": {
    "doi": "10.1007/s12032-014-0460-3"
  },
  "publisher": "Springer Science and Business Media LLC",
  "title": "Erratum to: Single-agent bevacizumab is an effective treatment in recurrent glioblastoma"
}
